SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 11.54% to Rs. 16045.90 millions for the quarter ended March 2025 as compared to Rs. 14386.30 millions during the corresponding quarter last year.A comparatively good net profit growth of 27.86% to Rs. 3670.40 millions was reported for the quarter ended March 2025 compared to Rs. 2870.60 millions of previous same quarter.The company reported a good operating profit of 5045.60 millions compared to 4106.80 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 16045.90 14386.30 11.54 64091.50 58489.10 9.58 64091.50 58489.10 9.58
Other Income 760.20 811.50 -6.32 2755.80 2482.70 11.00 2755.80 2482.70 11.00
PBIDT 5045.60 4106.80 22.86 19701.80 17013.70 15.80 19701.80 17013.70 15.80
Interest 39.20 28.10 39.50 114.30 124.50 -8.19 114.30 124.50 -8.19
PBDT 5006.40 4078.70 22.74 19587.50 16889.20 15.98 19587.50 16889.20 15.98
Depreciation 179.30 181.90 -1.43 718.00 711.70 0.89 718.00 711.70 0.89
PBT 4827.10 3896.80 23.87 18869.50 16177.50 16.64 18869.50 16177.50 16.64
TAX 1156.70 1026.20 12.72 4725.10 4165.30 13.44 4725.10 4165.30 13.44
Deferred Tax 10.80 67.90 -84.09 27.20 10.70 154.21 27.20 10.70 154.21
PAT 3670.40 2870.60 27.86 14144.40 12012.20 17.75 14144.40 12012.20 17.75
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 31.44 28.55 10.15 30.74 29.09 5.68 30.74 29.09 5.68

Abbott India Share Price

27776.95 1115.50 (4.18%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×